Arkolith/Insider Trading/PHGE/Form 4

Solomon Jonathan Eitan

Chief Executive Officer, DirectorBiomX Inc. (PHGE) · full profile →Form 4 · filed Dec 13, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
0 non-derivative · 6 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 11, 2023Grant(A)146K——146K
Dec 11, 2023Disposed to issuer(D)144K——0
Dec 11, 2023Grant(A)38K——38K
Dec 11, 2023Disposed to issuer(D)152K——0
Dec 11, 2023Grant(A)40K——40K
Dec 11, 2023Disposed to issuer(D)205K——0

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-23-095417) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for BiomX Inc.

Build

Ask your agent about PHGE insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001213900-23-095417"
Ask your agent
Use Arkolith to summarize insider buying and selling at BiomX Inc.
over the last 90 days and cite the filings.